icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Big Pharma blockbuster & gold gets its glimmer back

Big Pharma is back in the spotlight as a major merger is now official. AbbVie has scooped up Allergan in a blockbuster deal. Adam Mesh of the Adam Mesh Trading Group is standing by to break it down. Stocks are in choppy waters as Trump and Xi are set to meet at the G20 in Japan later this week, where some are hoping for progress in the trade and tariff fight; Alex Mihailovich is on hand to help us sort through what lies ahead for the markets. And, as we see global markets entering uncertain territory, one precious metal has regained its shine. Peter Schiff of Euro Pacific Capital will be joining us to dig into gold’s recent tear.

Big Pharma blockbuster & gold gets its glimmer back
The boom/bust cycle is as old as Western banking itself. Our hosts break through the mainstream headlines to find the stories that matter, and help you navigate the booms and the busts.